Isofol Medical AB (publ) (STO:ISOFOL)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.432
+0.011 (0.77%)
May 15, 2025, 5:29 PM CET
104.86%
Market Cap 231.29M
Revenue (ttm) n/a
Net Income (ttm) -43.49M
Shares Out 161.52M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 255,441
Average Volume 358,150
Open 1.431
Previous Close 1.421
Day's Range 1.390 - 1.467
52-Week Range 0.652 - 4.885
Beta 1.36
RSI 32.49
Earnings Date May 21, 2025

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 5
Stock Exchange Nasdaq Stockholm
Ticker Symbol ISOFOL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.